NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY.

Disinformation can be deadly.

Links for educational purposes:

An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy – Nature Medicine

Abstract

The COVID-19 ‘infodemic’ continues to undermine trust in vaccination efforts aiming to bring an end to the pandemic. However, the challenge of vaccine hesitancy is not only a problem of the information ecosystem and it often has little to do with the vaccines themselves. In this Perspective, we argue that the epidemiological and social crises brought about by COVID-19 have magnified widely held social anxieties and trust issues that, in the unique circumstances of this global pandemic, have exacerbated skepticism toward vaccines. We argue that trust is key to overcoming vaccine hesitancy, especially in a context of widespread social uncertainty brought about by the pandemic, where public sentiment can be volatile. Finally, we draw out some implications of our argument for strategies to build vaccine confidence.

References

  1. WHO Director General. Munich Security Conference Speech. http://www.who.int/director-general/speeches/detail/munich-security-conference (2020).

  2. Josephson, A. & Lambe, E. Brand communications in time of crisis. Twitter Blog http://blog.twitter.com/en_us/topics/company/2020/Brand-communications-in-time-of-crisis (2020).

  3. Loomba, S., de Figueiredo, A., Piatek, S. J., de Graaf, K. & Larson, H. J. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat. Hum. Behav. 5, 337–348 (2021).

    Article  Google Scholar

  4. Puri, N., Coomes, E. A., Haghbayan, H. & Gunaratne, K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum. Vaccines Immunotherapeutics 16, 2586–2593 (2020).

    Article  CAS  Google Scholar

  5. Bickert, M. Combatting vaccine misinformation. Facebook Newsroom http://about.fb.com/news/2019/03/combatting-vaccine-misinformation/ (2019).

  6. O’Donovan, C. YouTube Just demonetized anti-vax channels. BuzzFeed News http://www.buzzfeednews.com/article/carolineodonovan/youtube-just-demonetized-anti-vax-channels (2019).

  7. Center for Countering Digital Hate. The Anti-Vaxx Industry https://www.counterhate.com/anti-vaxx-industry (2020).

  8. Bickert, M. How we’re taking action against vaccine misinformation superspreaders. Facebook Newsroom http://about.fb.com/news/2021/08/taking-action-against-vaccine-misinformation-superspreaders/ (2021).

  9. Byford, J. Conspiracy Theories: A Critical Introduction (Palgrave Macmillan, 2011).

  10. van Prooijen, J.-W. & Douglas, K. M. Conspiracy theories as part of history: the role of societal crisis situations. Mem. Stud. 10, 323–333 (2017).

    Article  Google Scholar

  11. Ahmed, W., Vidal-Alaball, J., Downing, J. & López Seguí, F. COVID-19 and the 5G conspiracy theory: social network analysis of twitter data. J. Med. Internet Res. 22, e19458 (2020).

    Article  Google Scholar

  12. Bruns, A., Harrington, S. & Hurcombe, E. ‘Corona? 5G? or both?’: the dynamics of COVID-19/5G conspiracy theories on Facebook. Media Int. Aust. 177, 12–29 (2020).

    Article  Google Scholar

  13. Waterson, J. & Hern, A. At least 20 UK phone masts vandalised over false 5G coronavirus claims. The Guardian (2020).

  14. Frankovic, K. Why won’t Americans get vaccinated? YouGov America https://today.yougov.com/topics/politics/articles-reports/2021/07/15/why-wont-americans-get-vaccinated-poll-data (2021).

  15. Larson, H. J. Stuck: How Vaccine Rumors Start – and Why They Don’t Go Away (Oxford Univ. Press, 2020).

  16. Kennedy, J. Populist politics and vaccine hesitancy in Western Europe: an analysis of national-level data. Eur. J. Public Health 29, 512–516 (2019).

    Article  Google Scholar

  17. Baumgaertner, B., Carlisle, J. E. & Justwan, F. The influence of political ideology and trust on willingness to vaccinate. PLoS ONE 13, e0191728 (2018).

    Article  Google Scholar

  18. Abalakina-Paap, M., Stephan, W. G., Craig, T. & Gregory, W. L. Beliefs in conspiracies. Political Psychol. 20, 637–647 (1999).

    Article  Google Scholar

  19. Goertzel, T. Belief in conspiracy theories. Political Psychol. 15, 731–742 (1994).

    Article  Google Scholar

  20. Larson, H. J. et al. Measuring trust in vaccination: a systematic review. Hum. Vaccin. Immunother. 14, 1599–1609 (2018).

    Article  Google Scholar

  21. Ward, J. K. et al. ‘I don’t know if I’m making the right decision’: French mothers and HPV vaccination in a context of controversy. Health Risk Soc. 19, 38–57 (2017).

    Article  Google Scholar

  22. Figueiredo, A., de, Simas, C., Karafillakis, E., Paterson, P. & Larson, H. J. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet 396, 898–908 (2020).

    Article  Google Scholar

  23. Razai, M. S., Osama, T., McKechnie, D. G. J. & Majeed, A. Covid-19 vaccine hesitancy among ethnic minority groups. Brit. Med. J. 372, n513 (2021).

    Article  Google Scholar

  24. Wise, J. Pfizer accused of testing new drug without ethical approval. Brit. Med. J. 322, 194 (2001).

    Article  CAS  Google Scholar

  25. Jegede, A. S. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Med. 4, e73 (2007).

    Article  Google Scholar

  26. YouGov. YouGov-Cambridge Globalism 2020. https://docs.cdn.yougov.com/msvke1lg9d/Globalism2020%20Guardian%20Conspiracy%20Theories.pdf (2020).

  27. Larson, H. J. & Broniatowski, D. A. Volatility of vaccine confidence. Science https://doi.org/10.1126/science.abi6488 (2021).

  28. Paterson, P. & Pertwee, E. How will COVID-19 vaccine safety concerns impact vaccine confidence? The BMJ Opinion http://blogs.bmj.com/bmj/2021/04/16/how-will-the-uks-decision-to-offer-an-alternative-to-the-oxford-astrazeneca-covid-19-vaccine-for-under-30s-following-safety-signals-impact-vaccine-confidence/ (2021).

  29. YouGov. COVID-19 vaccine willingness tracker https://yougov.co.uk/topics/international/articles-reports/2021/01/12/covid-19-willingness-be-vaccinated (2021).

  30. Ofri, D. The emotional epidemiology of H1N1 influenza vaccination. N. Engl. J. Med. 361, 2594–2595 (2009).

    Article  CAS  Google Scholar

  31. Kahneman, D. Thinking, Fast and Slow. (Farrar, Straus and Giroux, 2012).

  32. Scrima, F., Miceli, S., Caci, B. & Cardaci, M. The relationship between fear of COVID-19 and intention to get vaccinated. The serial mediation roles of existential anxiety and conspiracy beliefs. Pers. Individ. Dif. 184, 111188 (2022).

    Article  Google Scholar

  33. Gronke, P. The politics and policy of Ebola. Political Sci. Politics 48, 3–18 (2015).

    Article  Google Scholar

  34. Bellato, A. Psychological factors underlying adherence to COVID-19 regulations: a commentary on how to promote compliance through mass media and limit the risk of a second wave. Soc. Sci. Humanities Open 2, 100062 (2020).

    Article  Google Scholar

  35. Goldenberg, A., Garcia, D., Halperin, E. & Gross, J. J. Collective emotions. Curr. Dir. Psychol. Sci. 29, 154–160 (2020).

    Article  Google Scholar

  36. Tengbeh, A. F. et al. ‘We are the heroes because we are ready to die for this country’: Participants’ decision-making and grounded ethics in an Ebola vaccine clinical trial. Soc. Sci. Med. 203, 35–42 (2018).

    Article  Google Scholar

  37. Larson, H., Simas, C. & Horton, R. The emotional determinants of health: the lancet–london school of hygiene & tropical medicine commission. Lancet 395, 768–769 (2020).

    Article  Google Scholar

  38. Peretti-Watel, P., Larson, H. J., Ward, J. K., Schulz, W. S. & Verger, P. Vaccine hesitancy: clarifying a theoretical framework for an ambiguous notion. PLoS Curr. https://doi.org/10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289 (2015).

  39. Corlett, E. New Zealand gang leaders unite to urge community to get Covid shots. The Guardian https://www.theguardian.com/world/2021/nov/03/new-zealand-vaccines-gang-leaders-unite-covid-shots (2021).

  40. de Figueiredo, A., Larson, H. J. & Reicher, S. D. The potential impact of vaccine passports on inclination to accept COVID-19 vaccinations in the United Kingdom: evidence from a large cross-sectional survey and modeling study. EClinicalMedicine 40, 101109 (2021).

    Article  Google Scholar

  41. Roozenbeek, J., S. van der Linden & Nygren, T. Prebunking interventions based on “inoculation” theory can reduce susceptibility to misinformation across cultures. Harvard Kennedy School Misinformation Review 1, 1–23 (2020).

  42. Basol, M., Roozenbeek, J. & van der. Linden, S. Good news about bad news: gamified inoculation boosts confidence and cognitive immunity against fake news. J. Cognition 3, 2 (2020).

    Article  Google Scholar

  43. Tariq, K. Finland most resilient to misinformation in classroom milieu. The Academia http://academiamag.com/finland-most-resilient-to-misinformation-in-classroom-milieu/ (2019).

2022-11-07T05:53:23+00:00
Forward Looking Statements. No Offer or Solicitation. Professional Investors Only.2023-02-03T11:00:00+00:00

This website includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “will,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include statements about our beliefs and expectations and the estimated financial information and other projections contained herein. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects and other aspects of the businesses of Normax Biomed Ltd. are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those expressed or implied by such forward-looking statements. Please refer to the final prospectus of Normax Biomed Limited under “Risk Factors” therein, and other documents filed or to be filed with the London Stock Exchange and the Swiss Stock Exchange (SIX) by Normax Biomed Ltd. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Normax Biomed Ltd. undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

The information on this website shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. The information on this website shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the listing requirements of the London Stock Exchange and the Swiss Stock Exchange (SIX).

This website is directed only at, and provides information about products and services only available to, those who are Professional Clients or Eligible Counterparties as defined by the Financial Conduct Authority. The definitions can be found on the FCA website at www.fca.org.uk. This website is not intended to be accessed by any persons or entities domiciled in any jurisdiction where being treated as the types of clients stated would be contrary to local law.

Normax Abstract2022-08-31T11:50:39+00:00

Normax Biomed Ltd (Normax) is based in Cork, Ireland, and London, England. Normax is in the business of mRNA vaccine Research, Development and Manufacturing. Normax has secured a €300,000,000 capital commitment from a $3.4Bn cornerstone institutional investor for development of mRNA Vaccines and Vax Factory Manufacturing for Transformative Social Impact on Infectious Disease and Pandemic Preparedness. Normax plans to drive down the cost of mRNA Vaccines to save more lives and to deliver sustainable returns for impact investors. Normax plans to deliver safe and effective mRNA vaccines at large scale for about $4 dollars per dose. Normax mRNA vaccine products in development include: (1) mRNA Vax Factory, (2) Universal Coronavirus mRNA Vaccine, (3) Tuberculosis mRNA Vaccine, (4) HIV mRNA Vaccine, (5) Malaria mRNA Vaccine, and (6) Disease-X mRNA Vaccine (e.g. within 100 days). Normax mission is to deliver competitive financial performance with transformative social impact. NOT AN OFFER TO INVEST.

Copyright 2021 | Normax Biomed Limited | First Floor, Penrose 1, Penrose Dock, Cork, Ireland | T23 KW81 | Company Number 669518

error: Content is protected !!
Go to Top